Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder. Hakobyan S, Luppe S, Evans D R, Harding K, Loveless S, Robertson NP, Morgan PB Mult Scler. 2016 Sep 9. PMID: 27613120. Abstract CommentRecommendBookmarkWatch